PLUR

NASDAQ 已收盘

Pluri

0.94 USD
▼-0.03-3.07%
盘后 0.99 +5.32%
2026-11-20
市值
$13.51M
市盈率
—
EPS
-2.69
股息率
—
52 周区间
0.85 – 4.12
成交量
25.87K
Beta
0.65
目标价
—
52W 低 0.8552W 高 4.12
价格走势

公司简介

Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. The company develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and an immunotherapy platform. Its product candidates include PLX-PAD, which is composed of maternal mesenchymal stromal cells originating from the placenta for the treatment of various indications, such as acute muscle...